Systematic (IUPAC) name | |
---|---|
(RS)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one | |
Clinical data | |
Trade names | Ocupress |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601078 |
Pregnancy cat. | C(US) |
Legal status | ℞ Prescription only |
Routes | Eye drops |
Pharmacokinetic data | |
Bioavailability | 85% |
Metabolism | Hepatic, active with 8-hydrocarteolol |
Half-life | 6–8 hours |
Excretion | Renal (50-70%) |
Identifiers | |
CAS number | 51781-06-7 |
ATC code | C07AA15 S01ED05 |
PubChem | CID 2583 |
DrugBank | APRD00195 |
ChemSpider | 2485 |
UNII | 8NF31401XG |
KEGG | D07624 |
ChEBI | CHEBI:3437 |
ChEMBL | CHEMBL839 |
Chemical data | |
Formula | C16H24N2O3 |
Mol. mass | 292.373 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Carteolol (trade names Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, Singlauc) is a non-selective beta blocker used to treat glaucoma.
|